Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision/version indicator was updated (to v3.5.3), reflecting a site update rather than a change to the clinical study information. Some generic related-topics/navigation labels (including a previous revision reference) were removed.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded related topics including Melanoma and MedlinePlus Genetics, and updated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check78 days agoChange DetectedThe related topics for Melanoma and MedlinePlus Genetics have been removed from the page.SummaryDifference0.1%

- Check85 days agoChange DetectedMelanoma tag was added and related topics such as MedlinePlus Genetics were included. The revision note was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page footer now shows Revision: v3.4.1, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.